PDCD1 and neoplasm: Mice in groups treated with CD5-2 (with or without anti-PD1) exhibited increased VE-Cadherin expression in tumors, but not in adjacent non-tumor liver tissue compared to mice treated with control Blockmir or no treatment (Figures 4A–D).